Differences between professionals in treatment planning for patients with stage III lung cancer using treatment-planning QA software.

Autor:	Sato D; Graduate School of Health Sciences, Tokushima University, Tokushima, Japan., Sasaki M; Department of Therapeutic Radiology, Institute of Biomedical Sciences, Tokushima University Graduate School, Tokushima, Japan., Nakaguchi Y; Toyo Medic Co., Ltd, Tokyo, Japan., Kamomae T; Department of Radiology, Graduate School of Medicine, Nagoya University Nagoya, Japan., Kawanaka T; Department of Radiology and Radiation Oncology, Institute of Biomedical Sciences, Graduate School, Tokushima University Tokushima, Japan., Kubo A; Department of Radiology and Radiation Oncology, Institute of Biomedical Sciences, Graduate School, Tokushima University Tokushima, Japan., Tonoiso C; Department of Radiology and Radiation Oncology, Institute of Biomedical Sciences, Graduate School, Tokushima University Tokushima, Japan., Kanazawa Y; Department of Medical Image Informatics, Institute of Biomedical Sciences, Graduate School, Tokushima University, Tokushima, Japan., Oita M; Division of Radiological Technology, Graduate School of Interdisciplinary Science and Engineering in Health Systems, Okayama University, Okayama, Japan., Kajino A; Department of Therapeutic Radiology, Institute of Biomedical Sciences, Tokushima University Graduate School, Tokushima, Japan., Tsuzuki A; Department of Radiological Technology, Kakogawa Central City Hospital, Kakogawa, Japan., Ikushima H; Department of Therapeutic Radiology, Institute of Biomedical Sciences, Tokushima University Graduate School, Tokushima, Japan.
Jazyk:	angličtina
Zdroj:	Reports of practical oncology and radiotherapy : journal of Greatpoland Cancer Center in Poznan and Polish Society of Radiation Oncology [Rep Pract Oncol Radiother] 2023 Nov 16; Vol. 28 (5), pp. 671-680. Date of Electronic Publication: 2023 Nov 16 (Print Publication: 2023).
DOI:	10.5603/rpor.97511
Abstrakt:	Background: The quality of treatment planning for stage III non-small cell lung cancer varies within and between facilities due to the different professions involved in planning. Dose estimation parameters were calculated using a feasibility dose-volume histogram (FDVH) implemented in the treatment planning quality assurance software PlanIQ. This study aimed to evaluate differences in treatment planning between occupations using manual FDVH-referenced treatment planning to identify their characteristics. Materials and Methods: The study included ten patients with stage III non-small cell lung cancer, and volumetric-modulated arc therapy was used as the treatment planning technique. Fifteen planners, comprising five radiation oncologists, five medical physicists, and five radiological technologists, developed treatment strategies after referring to the FDVH. Results: Medical physicists had a higher mean dose at D98% of the planning target volume (PTV) and a lower mean dose at D2% of the PTV than those in other occupations. Medical physicists had the lowest irradiation lung volumes (V5 Gy and V13 Gy) compared to other professions, and radiation oncologists had the lowest V20 Gy and mean lung dose. Radiological technologists had the highest irradiation volumes for dose constraints at all indexes on the normal lung volume. Conclusions: The quality of the treatment plans developed in this study differed between occupations due to their background expertise, even when an FDVH was used as a reference. Therefore, discussing and sharing knowledge and treatment planning techniques among professionals is essential to determine the optimal treatment plan for each facility and patient. Competing Interests: Conflict of interest: Yuji Nakaguchi is an employee of TOYO MEDIC CO., LTD. (© 2023 Greater Poland Cancer Centre.)
Databáze:	MEDLINE
Externí odkaz:	Zobrazit plný text záznamu